OBJECTIVES: This article examines the diagnosis and management of type-2 diabetes when exactly the same "patient" is encountered by 192 randomly selected primary care doctors in 3 different health care systems--the United States, United Kingdom, and Germany. METHODS: We conducted a factorial experiment, employing 2 clinically authentic filmed scenarios, to examine country differences in the treatment of diabetes, while controlling the effects of selected characteristics of patients and physicians. The patient in the first scenario presented with (undiagnosed) signs and symptoms strongly suggestive of diabetes, while the second scenario presented an already diagnosed patient with an emerging foot neuropathy. Physicians were asked how they would diagnose and manage the patients after watching the video vignettes using a questionnaire with standardized and open-ended questions. RESULTS: Regarding the first (undiagnosed) case, US doctors would ask significantly more questions than physicians from the UK and Germany (P < 0.001). German physicians would give less advice but would want to see the patient again much sooner (P < 0.001). Regarding the diagnosed case with an emerging foot neuropathy, US physicians would be most active in terms of questioning, testing, prescribing, and advice giving. Again, physicians from Germany would be less active in terms of therapeutic strategies but they would like to see the patient again sooner (P = 0.005). CONCLUSIONS: Although physicians in the 3 countries encountered exactly the same patient, differences in diagnostic and management decisions were evident. The experimental design provides unconfounded estimates of health system differences while simultaneously controlling for the effects of selected patient attributes and physician characteristics.
OBJECTIVES: This article examines the diagnosis and management of type-2 diabetes when exactly the same "patient" is encountered by 192 randomly selected primary care doctors in 3 different health care systems--the United States, United Kingdom, and Germany. METHODS: We conducted a factorial experiment, employing 2 clinically authentic filmed scenarios, to examine country differences in the treatment of diabetes, while controlling the effects of selected characteristics of patients and physicians. The patient in the first scenario presented with (undiagnosed) signs and symptoms strongly suggestive of diabetes, while the second scenario presented an already diagnosed patient with an emerging foot neuropathy. Physicians were asked how they would diagnose and manage the patients after watching the video vignettes using a questionnaire with standardized and open-ended questions. RESULTS: Regarding the first (undiagnosed) case, US doctors would ask significantly more questions than physicians from the UK and Germany (P < 0.001). German physicians would give less advice but would want to see the patient again much sooner (P < 0.001). Regarding the diagnosed case with an emerging foot neuropathy, US physicians would be most active in terms of questioning, testing, prescribing, and advice giving. Again, physicians from Germany would be less active in terms of therapeutic strategies but they would like to see the patient again sooner (P = 0.005). CONCLUSIONS: Although physicians in the 3 countries encountered exactly the same patient, differences in diagnostic and management decisions were evident. The experimental design provides unconfounded estimates of health system differences while simultaneously controlling for the effects of selected patient attributes and physician characteristics.
Authors: Jennifer A Mayfield; Gayle E Reiber; Lee J Sanders; Dennis Janisse; Leonard M Pogach Journal: Diabetes Care Date: 2003-01 Impact factor: 19.112
Authors: H A Feldman; J B McKinlay; D A Potter; K M Freund; R B Burns; M A Moskowitz; L E Kasten Journal: Health Serv Res Date: 1997-08 Impact factor: 3.402
Authors: Olaf von dem Knesebeck; Markus Bönte; Johannes Siegrist; Lisa Marceau; Carol Link; Sara Arber; Ann Adams; John McKinlay Journal: BMC Health Serv Res Date: 2008-09-29 Impact factor: 2.655
Authors: Olaf von dem Knesebeck; Anke Hoehne; Carol Link; Lisa Marceau; Ann Adams; Martin Roland; Stephen Campbell; Johannes Siegrist; John McKinlay Journal: Patient Educ Couns Date: 2012-05-15
Authors: W de Cruppé; O von dem Knesebeck; E Gerstenberger; C Link; L Marceau; J Siegrist; M Geraedts; J McKinlay Journal: Dtsch Med Wochenschr Date: 2011-02-17 Impact factor: 0.628
Authors: Lisa C Welch; Heather J Litman; Christina P C Borba; Brenda Vincenzi; David C Henderson Journal: Health Serv Res Date: 2014-12-09 Impact factor: 3.402
Authors: Marjan Askari; Peter C Wierenga; Saied Eslami; Stephanie Medlock; Sophia E de Rooij; Ameen Abu-Hanna Journal: PLoS One Date: 2011-12-16 Impact factor: 3.240